351 related articles for article (PubMed ID: 9753220)
1. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action?
Tarnawski A; Arakawa T; Kobayashi K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):90S-98S. PubMed ID: 9753233
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
Sakurai K; Osaka T; Yamasaki K
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427
[TBL] [Abstract][Full Text] [Related]
4. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa.
Ishihara K; Komuro Y; Nishiyama N; Yamasaki K; Hotta K
Arzneimittelforschung; 1992 Dec; 42(12):1462-6. PubMed ID: 1337697
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
[TBL] [Abstract][Full Text] [Related]
6. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide induces the gastric mucosal protective factor, cyclooxygenase-2, via activation of 5'-AMP-activated protein kinase.
Lee S; Jeong S; Kim W; Kim D; Yang Y; Yoon JH; Kim BJ; Min DS; Jung Y
Biochem Biophys Res Commun; 2017 Jan; 483(1):449-455. PubMed ID: 28011266
[TBL] [Abstract][Full Text] [Related]
8. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications.
Arakawa T; Higuchi K; Fujiwara Y; Watanabe T; Tominaga K; Sasaki E; Oshitani N; Yoshikawa T; Tarnawski AS
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S3-S11. PubMed ID: 16184418
[TBL] [Abstract][Full Text] [Related]
9. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies indicating antioxidative properties of rebamipide.
Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
[TBL] [Abstract][Full Text] [Related]
11. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?
Tarnawski AS; Chai J; Pai R; Chiou SK
Dig Dis Sci; 2004 Feb; 49(2):202-9. PubMed ID: 15104358
[TBL] [Abstract][Full Text] [Related]
13. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
[TBL] [Abstract][Full Text] [Related]
14. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.
Aihara E; Hayashi S; Amagase K; Kato S; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):196-202. PubMed ID: 17943251
[TBL] [Abstract][Full Text] [Related]
16. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
[TBL] [Abstract][Full Text] [Related]
17. [The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract].
Yakovenko EP; Agafonova NA; Ivanov AN; Yakovenko AV; Aldiyarova MA; Volosheinikova TV; Grigoryeva YV; Soluyanova IP
Ter Arkh; 2016; 88(4):88-92. PubMed ID: 27070169
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Kim CD; Kim HH; Hong KW
J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
[TBL] [Abstract][Full Text] [Related]
19. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K
Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404
[TBL] [Abstract][Full Text] [Related]
20. Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice.
Watanabe T; Higuchi K; Taira K; Sasaki E; Shiba M; Tominaga K; Fujiwara Y; Oshitani N; Arakawa T
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S63-9. PubMed ID: 16184423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
